## **Core Concept**
The question tests the understanding of pharmacological management of psychiatric disorders, specifically the treatment of depression with psychotic features or treatment-resistant depression. Chlorpromazine is a typical antipsychotic primarily used for schizophrenia. When a patient's symptoms, such as auditory hallucinations, are not controlled by chlorpromazine, the next step involves considering alternative or adjunct treatments.

## **Why the Correct Answer is Right**
The correct answer, , involves adding an antidepressant to augment the treatment of depression or switching to a different class of medication that can address both depressive symptoms and psychotic features. In cases where a patient with depression does not respond to antipsychotic monotherapy (like chlorpromazine), adding an antidepressant or using a different antipsychotic with a broader therapeutic profile may be beneficial. Clozapine, an atypical antipsychotic, is particularly noted for its efficacy in treatment-resistant schizophrenia but can also be effective in mood disorders with psychotic features.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option might seem plausible but is less likely to be the immediate next step given its side effect profile and the fact that it's not primarily indicated for depression with psychotic features.
- **Option B:** - While another typical antipsychotic might be considered, simply switching within the same class may not provide a different therapeutic outcome, especially if the patient hasn't responded to chlorpromazine.
- **Option D:** - This option might not directly address the psychotic symptoms as effectively as an antipsychotic with a broader therapeutic profile.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in treatment-resistant depression or depression with psychotic features, augmentation strategies or switching to a medication with a different mechanism of action (like an atypical antipsychotic) can be effective. Clozapine stands out for its use in treatment-resistant cases.

## **Correct Answer:** .